FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.042 |
Evidence |
|
CIITA |
CIITA, MHC2TA: MHC class II transactivator |
CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
1.042 |
Evidence |
|
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.042 |
Evidence |
|
C1R |
C1R: Complement C1r subcomponent precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
1.042 |
Evidence |
|
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
1.042 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.042 |
Evidence |
|
RIN1 |
RIN1: Ras and Rab interactor 1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.042 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
SYK |
SYK: Tyrosine-protein kinase SYK |
1.042 |
Evidence |
|
CMA1 |
CMA1, CYH, CYM: Chymase precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.042 |
Evidence |
|
BMX |
IPI00514142 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.042 |
Evidence |
|
SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
1.042 |
Evidence |
|
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
1.042 |
Evidence |
|
CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
1.042 |
Evidence |
|
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
1.042 |
Evidence |
|
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
1.042 |
Evidence |
|
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.042 |
Evidence |
|
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.042 |
Evidence |
|
F8 |
F8, F8C: Coagulation factor VIII precursor |
MGP |
MGP, MGLAP, GIG36: Matrix Gla protein precursor |
1.042 |
Evidence |
|
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
1.042 |
Evidence |
|
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.042 |
Evidence |
|
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
1.042 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
1.042 |
Evidence |
|
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
1.042 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.042 |
Evidence |
|
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
C2 |
C2: Complement C2 precursor |
1.042 |
Evidence |
|